Alaunos Therapeutics Inc (TCRT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.86M
Last updated: Nov 17, 2026 at 11:05 AM ET
Alaunos Therapeutics Inc (TCRT) Earnings: Report Dates and Results
Alaunos Therapeutics (TCRT) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Alaunos Therapeutics reported EPS of -$0.41. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
TCRT has an expected report date of Mar 29, 2027.
Earnings History
Of the 33 quarters below that had an estimate, TCRT beat 19, missed 13 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2019, when EPS landed 377.78% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2026 | N/A |
| Sep 30, 2025 | -$0.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$0.67 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2025 | $2000 |
| Dec 31, 2024 | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2025 | $5000 |
| Sep 30, 2024 | -$0.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$0.71 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 14, 2024 | $4000 |
| Mar 31, 2024 | -$17.09 | -$4.50 | N/A | -279.78% | Miss | N/A | N/A | 0 up, 0 down | Apr 2, 2024 | $1000 |
| Dec 31, 2023 | -$0.49 | -$0.45 | -$0.45 - -$0.45 | -8.89% | Miss | N/A | 1 | 0 up, 0 down | Mar 5, 2024 | $1000 |
| Sep 30, 2023 | -$4.41 | -$5.25 | -$6.00 - -$4.50 | +16.00% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2023 | N/A |
| Jun 30, 2023 | -$6.00 | -$6.75 | -$7.50 - -$6.00 | +11.11% | Beat | N/A | 5 | 0 up, 0 down | Aug 14, 2023 | $4000 |
| Mar 31, 2023 | -$6.00 | -$6.60 | -$7.50 - -$6.00 | +9.09% | Beat | N/A | 6 | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$0.04 | -$0.07 | -$0.14 - -$0.04 | +42.86% | Beat | N/A | 6 | 0 up, 0 down | Mar 7, 2023 | $11000 |
| Sep 30, 2022 | -$6.00 | -$10.75 | -$25.49 - -$7.50 | +44.19% | Beat | N/A | 5 | 0 up, 0 down | Nov 14, 2022 | $2.91M |
| Jun 30, 2022 | -$7.50 | -$10.25 | -$25.49 - -$6.00 | +26.83% | Beat | N/A | 6 | 0 up, 0 down | Aug 15, 2022 | N/A |
| Mar 31, 2022 | -$7.50 | -$9.90 | -$19.49 - -$7.50 | +24.24% | Beat | N/A | 5 | 0 up, 0 down | May 16, 2022 | N/A |
| Dec 31, 2021 | -$0.05 | -$0.08 | -$0.11 - -$0.05 | +37.50% | Beat | N/A | 7 | 0 up, 0 down | Mar 30, 2022 | N/A |
| Sep 30, 2021 | -$16.50 | -$18.86 | N/A | +12.51% | Beat | N/A | N/A | N/A | Nov 8, 2021 | $398000 |
| Jun 30, 2021 | -$16.50 | -$17.57 | N/A | +6.09% | Beat | N/A | N/A | N/A | Aug 13, 2021 | N/A |
| Mar 31, 2021 | -$15.00 | -$15.81 | N/A | +5.12% | Beat | N/A | N/A | N/A | May 6, 2021 | N/A |
| Dec 31, 2020 | -$0.11 | -$0.10 | N/A | -10.00% | Miss | N/A | N/A | N/A | Feb 25, 2021 | N/A |
| Sep 30, 2020 | -$15.00 | -$13.49 | N/A | -11.19% | Miss | N/A | N/A | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | -$13.50 | -$13.75 | N/A | +1.82% | Beat | N/A | N/A | N/A | Aug 6, 2020 | N/A |
| Mar 31, 2020 | -$13.50 | -$12.75 | N/A | -5.88% | Miss | N/A | N/A | N/A | Apr 29, 2020 | N/A |
| Dec 31, 2019 | -$0.09 | -$0.08 | N/A | -12.50% | Miss | N/A | N/A | N/A | Mar 2, 2020 | N/A |
| Sep 30, 2019 | -$64.50 | -$13.50 | N/A | -377.78% | Miss | N/A | N/A | N/A | Nov 7, 2019 | N/A |
| Jun 30, 2019 | -$13.50 | -$12.24 | N/A | -10.29% | Miss | N/A | N/A | N/A | Aug 8, 2019 | N/A |
| Mar 31, 2019 | -$12.00 | -$12.30 | N/A | +2.44% | Beat | N/A | N/A | N/A | May 8, 2019 | N/A |
| Dec 31, 2018 | -$0.08 | -$0.11 | N/A | +27.27% | Beat | N/A | N/A | N/A | Mar 5, 2019 | N/A |
| Sep 30, 2018 | -$19.50 | -$16.73 | N/A | -16.56% | Miss | N/A | N/A | N/A | Nov 9, 2018 | $600000 |
| Jun 30, 2018 | -$18.00 | -$18.52 | N/A | +2.81% | Beat | N/A | N/A | N/A | Aug 8, 2018 | N/A |
| Mar 31, 2018 | -$22.50 | -$19.06 | N/A | -18.05% | Miss | N/A | N/A | N/A | Apr 30, 2018 | $146000 |
| Dec 31, 2017 | -$0.13 | -$0.14 | N/A | +7.14% | Beat | N/A | N/A | N/A | Mar 1, 2018 | $1.60M |
| Sep 30, 2017 | -$19.50 | -$20.29 | N/A | +3.89% | Beat | N/A | N/A | N/A | Nov 6, 2017 | $1.60M |
| Jun 30, 2017 | -$19.50 | -$18.43 | N/A | -5.81% | Miss | N/A | N/A | N/A | Jul 31, 2017 | $1.60M |
| Mar 31, 2017 | -$22.50 | -$14.22 | N/A | -58.23% | Miss | N/A | N/A | N/A | May 1, 2017 | $1.60M |
| Dec 31, 2016 | -$0.11 | -$0.11 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 16, 2017 | $1.60M |
| Sep 30, 2016 | -$16.50 | -$16.60 | N/A | +0.60% | Beat | N/A | N/A | N/A | Nov 9, 2016 | $1.60M |
| Jun 30, 2016 | -$15.00 | -$15.90 | N/A | +5.66% | Beat | N/A | N/A | N/A | Aug 9, 2016 | $1.70M |
| Mar 31, 2016 | -$13.50 | -$12.00 | N/A | -12.50% | Miss | N/A | N/A | N/A | May 10, 2016 | $1.97M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$18.96, after -$16.90 the year before. It was -$52.57 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$18.96 | N/A |
| Dec 31, 2023 | -$16.90 | N/A |
| Dec 31, 2022 | -$21.04 | N/A |
| Dec 31, 2021 | -$48.05 | N/A |
| Dec 31, 2020 | -$42.11 | N/A |
| Dec 31, 2019 | -$90.09 | N/A |
| Dec 31, 2018 | -$60.08 | N/A |
| Dec 31, 2017 | -$61.63 | N/A |
| Dec 31, 2016 | -$45.11 | N/A |
| Dec 31, 2015 | -$52.57 | N/A |
Frequently Asked Questions About TCRT
When is Alaunos Therapeutics's next earnings date?
Alaunos Therapeutics's next earnings report is expected for Mar 29, 2027.
How often does TCRT beat earnings estimates?
Alaunos Therapeutics beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of -17.32%.
TCRT pages: Overview, Earnings, Financials, Competitors